Caribou Biosciences vs Mindwalk Holdings
Caribou Biosciences and Mindwalk Holdings are similar in size: $11.2m and $11.3m of revenue in their latest fiscal years. Mindwalk Holdings grew faster (47.8% against 11.7%). Mindwalk Holdings kept more of each dollar of sales as profit: a net margin of -89.7% against -1327.4%. Caribou Biosciences carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Caribou BiosciencesCRBU, 2025 | Mindwalk HoldingsHYFT, 2026 |
|---|---|---|
| Revenue | $11.2m | $11.3m |
| Revenue growth | 11.7% | 47.8% |
| Net income | −$148m | −$10.1m |
| Operating margin | -1329.4% | — |
| Net margin | -1327.4% | -89.7% |
| Return on equity | -79.0% | -78.5% |
| Free cash flow | −$112m | −$9.3m |
| Cash | $12.4m | $8.4m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $47.4m | $50.6m |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | — |
| Insider trades, 12 months | 0 buys, 5 sales | 0 buys, 0 sales |